Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Team will deliver QP services in multiple dosage forms
August 12, 2013
By: Gil Roth
President, Pharma & Biopharma Outsourcing Association
Gareth Adlam has been named Quality Assurance director at the Nottingham, UK-based formulation and development site of Aesica Pharmaceuticals. As an experienced Qualified Person (QP), Mr. Adlam has 15 years of pharmaceutical expertise, including six years in practice as a QP professional. Prior to qualifying as a QP, he worked as a pharmacist, before taking on roles in scale up, product development and R&D compliance. In his new role, Mr. Adlam’s main goal is to drive batch certifying procedures and to bring high quality, best practice expertise to bear in QP services, applying his knowledge and success gained from his previous QP role to both small scale capabilities, as is the case at Nottingham, through to the larger commercial scale IMP sites in place within the Aesica Group. Aesica now has 15 QPs in operation across its Zwickau, Nottingham, Queenborough, Pianezza and Monheim sites, further enhancing its international offering to customers. The company performs full release of commercial products to the market, providing this service for the bulk of products that it currently manufactures. Aesica Pharmaceuticals has established a Quality Assurance team focused on delivering a range of Qualified Person (QP) services across oral, topical, inhalable and parenteral dosage forms in Investigational Medicinal Products (IMP) clinical trial release, combined with the capability to assess other alternative formats. The move is intended to enhance the QP service offering provided by Aesica through its network of qualified European QPs who routinely release clinical trial supplies into the clinic. It will also bolster the company’s QP EU release service offering for clinical trial products manufactured in non-EU countries, including in the U.S. QP services at Aesica include full specification testing, carried out at the company’s GMP analytical laboratories, thereby enabling products manufactured in the US to be used in EU based clinical trials. Furthermore, Aesica handles importation licenses as an additional service to customers.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !